Best of September 2025: Top 5 Insights In Clinical Supply Chain & Logistics

#1 - New Group Wants 'Phase-Appropriate' Thinking To Retire

A new industry group — the Cell&Gene Foundry — argues it’s time to reframe the conversation around risk, not phase. Explore why “risk-appropriate” strategies are the key to smarter automation, analytics, and scalability.

#2 - A New Approach To Meeting The Needs Of Early Phase Trials With IRT

As early phase clinical trials become more sophisticated, explore how sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

#3 - What Biotech Sponsors Should Look For In A CDMO For Sterile Fill/Finish

Learn why choosing the right CDMO partner for a biotech product isn’t about “capacity at a good price”; it’s about a partner with the right mix of technical expertise, regulatory track record, and more.

#4 - Navigating The Biopharma Finance & Accounting Tech Landscape From Pre-Clinical To Commercial Success

During clinical trials, the intricacies of financial management intensify, necessitating advanced ERP functionalities to handle clinical accruals, compliance, and reporting. Discover how to make smarter tech decisions at every growth stage 

#5 - What Sponsors Must Know About Digital Systems And AI Compliance

Consultant Jessica Cordes provides an update on proposed changes to GMP guidance that affect trial conduct, including documentation, computerized systems, and the use of AI.